Amid a push in Israel’s innovation ecosystem to develop new, commercially viable “deep-tech” products, a new Israeli grant program offering researchers up to $1.5 million over two years to help turn scientific breakthroughs into commercial technologies was announced on Monday.
The Bridge to Impact Grant, launched by Nevo Labs in partnership with Yad Hanadiv and other founding partners, will provide selected deep-tech projects with phased philanthropic funding to support research and development, along with professional mentorship and connections to industry experts.
The program targets projects based on scientifically validated discoveries or foundational technologies that have reached the applied development stage.
Funding will cover team salaries, materials, equipment, intellectual property expenses, and regulatory costs as researchers test their discoveries outside the laboratory and work to establish proof of concept, develop working prototypes, license technologies, or start companies. Similar support has helped Israeli biotech startups like X-tosis move laboratory research toward clinical application.
Grants will be disbursed in stages, contingent on meeting milestones outlined in each project’s work plan. Because the funding is structured as a philanthropic grant, it will not require changes to existing intellectual property arrangements at academic institutions, according to the program.
Dr. Asher Ragen, director of academic excellence at Yad Hanadiv, emphasized the importance of helping researchers move beyond laboratory testing.
“Israeli science holds tremendous potential to make a positive impact on the world. To realize that potential, researchers must receive comprehensive support in testing their findings under real-world field conditions and building an effective commercialization pathway,” he said.
“This new program is an innovative addition that will help scientists, academic institutions, and the State of Israel realize the potential of the exceptional science produced here,” he pointed out.
Connecting Israeli researchers with industry experts
Beyond financial support, the program will provide each participating team with three mentors selected from a pool of candidates proposed by Nevo Labs: an entrepreneur with hands-on experience, an active early-stage investor, and a senior scientist experienced in commercializing research.
A dedicated program manager will coordinate the mentors and other experts while connecting researchers with a network of scientists, entrepreneurs, investors, and industry leaders in Israel and internationally.
Sender Cohen, founding chairman of Nevo Labs and managing partner at ExB Group, highlighted the value of practical industry experience in helping researchers scale their technologies.
“When a team plans to move a process from the laboratory to a production line, someone who has already done it can help them anticipate where the process might break down as scale increases.”
“We want to connect researchers with people who hold that experience while they are still deciding what to test in their next experiment,” he added.
The program aims to “strengthen Israel’s scientific and technological ecosystem by establishing new infrastructure, expanding opportunities for outstanding researchers, and increasing the number of scientific discoveries that reach their full potential.”
According to the announcement, these efforts are also intended to contribute to the Israeli economy and reinforce the country’s commitment to investing in science and innovation.
Alex Tsigutkin, founder of AxiomSL, president of the Dijeruma Charitable Fund, and a founding partner of the Bridge to Impact Grant, underscored the potential economic benefits of turning scientific discoveries into commercial technologies.
“True commercial success begins when a discovery evolves into a real-world solution, grows into a platform, and ultimately gives rise to an entirely new industry.”
“Israel can benefit tremendously when her entrepreneurs commit to fulfill their potential,” he pointed out.
Supporting innovation from the laboratory to the market
The program will be operated by Nevo Labs, the multidisciplinary hub of the Nevo Science Foundation, a nonprofit organization established by investors from Israel and the US.
Its founding partners include Yad Hanadiv, Alex Tsigutkin, Alan Howard, and the Nevo Labs Board of Directors. Scott Tobin, senior partner at Battery Ventures, said that the importance of demonstrating practical applications for emerging technologies.
“When I evaluate a technology coming out of a lab, I ask who will try it first and what result will convince them to keep using it.”
“Once there is an answer, the team can define what they need to prove for the technology to move from an experiment to ongoing use,” he noted.
Scott Friedman, co-founder and partner at Soroban Capital Partners, highlighted the benefits of developing technologies in Israel while preparing them for international markets.
“When researchers lead development in Israel, they accumulate local experience here that can also be applied to future projects.”
“International partners can help the team understand early on which requirements recur across different markets, enabling them to develop technology in Israel that can also serve markets abroad,” he added.
